[PDF] Top 20 eBook Iso 31000 Gestion Riesgos Organizaciones
Has 10000 "eBook Iso 31000 Gestion Riesgos Organizaciones" found on our website. Below are the top 20 most common "eBook Iso 31000 Gestion Riesgos Organizaciones".
Ethical challenges with the left ventricular assist device as a destination therapy
... new ethical question: should presumed or sur- rogate consent substitute for first-person consent in emergency situations to authorize the use of these tempo- rary short-term mechanical circulatory devices in ... See full document
160
Left ventricular assist device implantation in high risk destination therapy patients: an alternative surgical approach
... Left Ventricular Assist Device (LVAD) for Destination Therapy (DT) has been an established therapy for over a decade [1] with the Heartmate VE™ and more recently with the ... See full document
7
Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure –1 year results from the Ce mark trial
... The HeartMate 3 Left Ventricular Assist System (LVAS) (St. Jude Medical Inc., St. Paul, MN) was designed for enhanced hemocompatibility by the inte- gration of a fully magnetically levitated rotor ... See full document
5
Right ventricular failure following left ventricular assist device implantation is associated with a preoperative pro-inflammatory response
... right ventricular stroke work index, as well as a greater incidence and dur- ation of preoperative ...with destination therapy LVAD without the acute shock presentation requiring ... See full document
28
Do Continuous Flow LVADS Improve Diastolic Dysfunction?
... Background: Ventricular assist devices are now used as a bridge to recovery/decision/transplant or as destination therapy in end-stage heart ...post left ventricular ... See full document
184
Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004–2011
... large device size, high cost and device-related complications limited the use of LVADs at that ...these challenges, Hernandez et al 8 reported that LVAD implantation ... See full document
6
Modeling payback from research into the efficacy of left ventricular assist devices as destination therapy
... a device cost- ing £20,000 will be taken knowing that there is a 28 percent chance that the therapy will be cost-effective, because of the uncertainties surrounding the survival ...the device is ... See full document
123
Matters to address prior to introducing new life support technology in Japan: three serious ethical concerns related to the use of left ventricular assist devices as destination therapy and suggested policies to deal with them
... from therapy: life expectancy of longer than 2 years due to heart failure, average life expectancy of less than 5 years due to the presence of other diseases, 65 years of age or older, a body mass index over 25, ... See full document
10
Resternotomy does not adversely affect outcome after left ventricular assist device implantation
... of left ventricular ejection fraction (LVEF) and cardiac index (CI) did not differ significantly between groups, but a higher mean pulmo- nary artery pressure (mean PAP) was found in the rester- notomy ... See full document
8
Mechanical circulatory support for advanced heart failure : are we about to witness a new "gold standard"?
... on left and right ventricular contraction with one-fibre model [94], systemic, pulmonary and coronary circulation based on lumped parameter models with heart rate regulation by a baroriflex ...the ... See full document
315
Is there a difference in bleeding after left ventricular assist device implant: centrifugal versus axial?
... All patients who underwent implantation of a CF-LVAD from July 2010 to July 2015 (n = 139) at the University of Pennsylvania were retrospectively reviewed. After initial data accrual, all patient identifiers were removed ... See full document
145
Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device – the role of anticoagulation
... To our knowledge, no randomized clinical trial on antic- oagulation in patients with VAD, has ever been performed. We have previously performed a systematic review on the relation between anticoagulation protocols and ... See full document
33
Accuracy of the Masimo Pronto-7® system in patients with left ventricular assist device
... 21 Caucasian patients (13 male, 8 female) from the spe- cialized outpatient division for assist device patients of the Clinic for Cardiothoracic and Vascular Surgery of Aachen University Hospital were ... See full document
15
Emergency laparoscopic cholecystectomy for intraabdominal hemorrhage in a patient with a left ventricular assist device: a case report
... anticoagulation therapy with only oral warfarin that had maintained the prothrombin time-international normal- ized ratio (PT-INR) between ...ventilation therapy for heart failure and had a nasogastric tube ... See full document
24
Experiences of being maintained on a ventricular assist device
... This thesis comprises two main pieces of research, a literature review and an empirical study. The literature review addressed the experience of decision-making for patients and caregivers regarding the LVAD implant ... See full document
12
Mechanical Circulatory Support Devices for Cardiogenic Shock: State of the Art
... Vasopressors: norepinephrine is considered the vasopressor of choice in cardiogenic shock. Subgroup analysis of patients with cardiogenic shock suggested lower mortality with norepinephrine compared to dopamine [14]. It ... See full document
8
Development of a direct mechanical ventricular assist device
... DEVELOPMENT OF THE ASSIST DEVICE Design Criteria Materials and Equipment Laboratory Studies Laboratory set-up Design process using artificial ventricle Animal Studies Surgical procedure [r] ... See full document
11
Numerical Study of a Left Ventricular Assist Device (LVAD) With Different Blade Heights and Tip Clearances
... The pump design process of this study utilized standard existing industrial centrifugal pump principles extrapolated down to the sizes needed for a blood pump. Two design parameters of the pump were studied; the impeller ... See full document
20
Development and characterization of the arterial windkessel and its role during left ventricular assist device assistance
... interpretation challenges the widely accepted wave-reflection mechanism of pressure augmentation, which does not take into account the "cushioning" effect of the aortic reservoir but only the reflected ... See full document
Advanced Heart Failure Treatment Options Among the Elderly
... as destination therapy) and elect to pursue this option, then appropriate education of both patient and caregivers is ...undergone destination therapy LVAD for AHF, we deploy the same ... See full document
23
Related subjects